Contact UsInvestorsCareersMediaScienceContact Us
Working for Patients with PatientsPatient centricity exists at Pfizer when we listen and learn from the patient perspective, acting as partners with accountability and integrity, to deliver outcomes that matter to patients and those involved in their care.HomeHelping CommunitiesOur work with patient groups

Our Work with Patient Groups

At Pfizer, patients are at the heart of everything that we do. 

We recognize that individuals living with a given health condition are the ones who know best about the impact their disease has on their life, including the challenges and needs associated with it. One of the ways Pfizer works to ensure that we meet those needs is by working with patient groups who have a direct connection with the communities they represent.

Collaborating with Patient Group

We believe that respectful and ethically sound engagements with patient groups are essential to fulfill our purpose.

This allows us to gain insights such as a better understanding of the burden of disease, gaps in care or information, barriers to accessing treatment and more, enabling us to focus our efforts on what truly matters to patients. Our work with patient groups typically takes the form of collaborations and/or arms-length financial support to drive initiatives focused on improving patient outcomes and/or health equity matters in areas of shared interest.

Our Commitment to Ethics and Transparency

Pfizer values the essential role that patient groups play in the healthcare ecosystem. Based on mutual respect, our interactions with patient groups always adhere to high ethical standards and reflect the independence of the parties.

Pfizer ensures that relationships with patient organizations are conducted in strict compliance with relevant laws and regulations, industry codes, external standards and internal Pfizer policies and procedures.

Pfizer will only support and engage with patient groups who share the same strong commitment to ethics and integrity, have diverse sources of funding and who can confirm having appropriate governance in place to ensure independence of action.

Collaborating with Patient Group

Therapeutic Areas of Focus

There are numerous patient organizations in Canada that do important and meaningful work. As a result, the demand is too high to allow Pfizer to approve each request for support we receive. To help guide funding decisions, Pfizer prioritizes providing support to patient groups and projects that align with our current therapeutic areas of focus.

At Pfizer, we strongly believe that every person deserves to be seen, heard, and cared for. Other factors we consider when assessing funding requests are initiatives that support health equity and contribute to reducing healthcare disparities across the country.

COVID-19

C. difficile

Diabetes

Inflammation & Immunology

Alopecia areata 
Atopic dermatitis 
Inflammatory bowel disease 
Rheumatology (e.g., rheumatoid arthritis) 
Iron Deficiency Anemia

Lyme disease

Migraine

Obesity

Oncology

Breast cancer 
Colorectal cancer 
Genitourinary cancers (bladder, kidney, prostate) 
Hematology (leukemia, multiple myeloma) 
Lung cancer 
Skin cancer (melanoma

Pneumococcal disease 

Rare Diseases 

Hemophilia 
Sickle cell disease  
Transthyretin amyloidosis cardiomyopathy (ATTR-CM)

Respiratory syncytial virus (RSV) 

Requests for Support

All requests for support must be made online.
Before initiating your request and making your submission, please review our application criteria and process.

Learn More 
About UsOur ProductsHelping CommunitiesOur Voice Suppliers Distribution ChannelPfizer WorldwideMedia CentreTerms Of Use Careers Healthcare ProfessionalsContact UsPrivacy PolicyCopyright © Pfizer Canada 2025 All rights reserved. The information is intended only for residents of Canada. ® Pfizer Inc, used under license